Journey Medical Corporation (DERM) DCF Valuation
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Journey Medical Corporation (DERM) Bundle
Explore the financial outlook of Journey Medical Corporation (DERM) with our user-friendly DCF Calculator! Enter your projections for growth, margins, and costs to calculate the intrinsic value of Journey Medical Corporation (DERM) and shape your investment approach.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 34.9 | 44.5 | 63.1 | 73.7 | 79.2 | 97.7 | 120.5 | 148.7 | 183.4 | 226.3 |
Revenue Growth, % | 0 | 27.52 | 41.78 | 16.69 | 7.48 | 23.37 | 23.37 | 23.37 | 23.37 | 23.37 |
EBITDA | 6.4 | 9.4 | -32.8 | -23.2 | 1.9 | -8.1 | -10.0 | -12.3 | -15.2 | -18.8 |
EBITDA, % | 18.44 | 21.03 | -51.9 | -31.47 | 2.43 | -8.29 | -8.29 | -8.29 | -8.29 | -8.29 |
Depreciation | 1.2 | 1.5 | 2.6 | 4.4 | 3.9 | 4.2 | 5.2 | 6.5 | 8.0 | 9.8 |
Depreciation, % | 3.45 | 3.4 | 4.05 | 5.93 | 4.87 | 4.34 | 4.34 | 4.34 | 4.34 | 4.34 |
EBIT | 5.2 | 7.9 | -35.3 | -27.5 | -1.9 | -12.3 | -15.2 | -18.8 | -23.2 | -28.6 |
EBIT, % | 14.99 | 17.63 | -55.95 | -37.39 | -2.44 | -12.63 | -12.63 | -12.63 | -12.63 | -12.63 |
Total Cash | 4.8 | 8.2 | 49.1 | 32.0 | 27.4 | 36.7 | 45.3 | 55.9 | 69.0 | 85.1 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 19.0 | 23.9 | 23.1 | 28.2 | 15.2 | 39.5 | 48.7 | 60.1 | 74.1 | 91.5 |
Account Receivables, % | 54.28 | 53.73 | 36.61 | 38.29 | 19.22 | 40.43 | 40.43 | 40.43 | 40.43 | 40.43 |
Inventories | .9 | 1.4 | 9.9 | 14.2 | 10.2 | 10.4 | 12.9 | 15.9 | 19.6 | 24.1 |
Inventories, % | 2.45 | 3.15 | 15.62 | 19.22 | 12.89 | 10.67 | 10.67 | 10.67 | 10.67 | 10.67 |
Accounts Payable | 2.1 | 2.0 | 22.8 | 37.0 | 18.1 | 23.4 | 28.8 | 35.6 | 43.9 | 54.2 |
Accounts Payable, % | 6.04 | 4.39 | 36.13 | 50.2 | 22.92 | 23.94 | 23.94 | 23.94 | 23.94 | 23.94 |
Capital Expenditure | -2.4 | -1.2 | -10.0 | -20.0 | -5.0 | -11.5 | -14.2 | -17.5 | -21.6 | -26.6 |
Capital Expenditure, % | -6.87 | -2.69 | -15.84 | -27.15 | -6.31 | -11.77 | -11.77 | -11.77 | -11.77 | -11.77 |
Tax Rate, % | -6.08 | -6.08 | -6.08 | -6.08 | -6.08 | -6.08 | -6.08 | -6.08 | -6.08 | -6.08 |
EBITAT | 3.8 | 5.8 | -36.7 | -27.6 | -2.1 | -11.0 | -13.6 | -16.8 | -20.7 | -25.5 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -15.1 | .4 | -30.9 | -38.5 | -5.1 | -37.5 | -28.7 | -35.5 | -43.7 | -54.0 |
WACC, % | 8.46 | 8.48 | 8.96 | 8.96 | 8.96 | 8.76 | 8.76 | 8.76 | 8.76 | 8.76 |
PV UFCF | ||||||||||
SUM PV UFCF | -153.1 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -55 | |||||||||
Terminal Value | -814 | |||||||||
Present Terminal Value | -535 | |||||||||
Enterprise Value | -688 | |||||||||
Net Debt | -10 | |||||||||
Equity Value | -678 | |||||||||
Diluted Shares Outstanding, MM | 18 | |||||||||
Equity Value Per Share | -37.21 |
What You Will Get
- Real DERM Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
- Scenario Analysis: Evaluate various scenarios to assess Journey Medical Corporation's future performance.
- User-Friendly Design: Designed for professionals while remaining approachable for newcomers.
Key Features
- Comprehensive DCF Calculator: Features both unlevered and levered DCF valuation models tailored for Journey Medical Corporation (DERM).
- WACC Calculator: Includes a pre-configured Weighted Average Cost of Capital sheet with adjustable inputs.
- Customizable Forecast Assumptions: Easily alter growth rates, capital expenditures, and discount rates.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to Journey Medical Corporation (DERM).
- Interactive Dashboard and Charts: Visual representations highlight essential valuation metrics for straightforward analysis.
How It Works
- Step 1: Download the prebuilt Excel template featuring Journey Medical Corporation’s (DERM) data.
- Step 2: Navigate through the pre-filled sheets to grasp the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see recalculated results, including Journey Medical Corporation’s (DERM) intrinsic value.
- Step 5: Make informed investment choices or create reports based on the outputs.
Why Choose This Calculator?
- Accuracy: Utilizes real Journey Medical Corporation (DERM) financials to ensure data precision.
- Flexibility: Tailored for users to easily adjust and test various inputs.
- Time-Saving: Avoid the complexity of constructing a DCF model from the ground up.
- Professional-Grade: Crafted with the precision and usability expected at the CFO level.
- User-Friendly: Intuitive design makes it accessible for individuals without extensive financial modeling skills.
Who Should Use This Product?
- Investors: Assess Journey Medical Corporation’s (DERM) valuation before making investment decisions.
- CFOs and Financial Analysts: Optimize valuation methodologies and evaluate financial forecasts.
- Startup Founders: Discover how established companies like Journey Medical Corporation are valued in the market.
- Consultants: Create detailed valuation reports for clients using Journey Medical Corporation’s (DERM) data.
- Students and Educators: Utilize real-time data to learn and teach valuation strategies effectively.
What the Template Contains
- Pre-Filled Data: Includes Journey Medical Corporation’s historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze Journey Medical Corporation’s profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.